Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$27.39 +1.19 (+4.54%)
At close: Nov 10, 2026 · 4:00 PM EST

Arcutis Biotherapeutics (ARQT) Return on Equity [ROE] (2020 - 2026)

Updated

Arcutis Biotherapeutics (ARQT) posted Return on Equity [ROE] of 13.89% for Q2 2026, up 80.13 percentage points from -66.24% a year earlier and up 15.16 percentage points from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Arcutis Biotherapeutics' Return on Equity [ROE] came in at -9.32%, up 104.44 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +123.61 percentage points (FY2020 to FY2025).
  • In prior years, Arcutis Biotherapeutics' Return on Equity [ROE] was -113.76% in FY2024 (+62.03 pp), -175.79% in FY2023 (-52.99 pp), -122.80% in FY2022 (-50.18 pp) and -72.62% in FY2021 (+60.31 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] in data going back to Q1 2020.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last ten quarters, with an average year-over-year change of +127.14 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2024, with a gain of 307.11 percentage points; the weakest was Q3 2023, with a drop of 287.55 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -1.27% (Q1 2026), -9.31% (Q4 2025) and -29.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Arcutis Biotherapeutics 3.45 Bn 2.51 Bn 131.46 Mn 12.66%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.66%
Jun 30, 2026 13.66%
Mar 31, 2026 -1.46%
Dec 31, 2025 -9.32%
Sep 30, 2025 -30.23%
Jun 30, 2025 -66.05%
Mar 31, 2025 -86.43%
Dec 31, 2024 -89.15%
Sep 30, 2024 -113.57%
Jun 30, 2024 -96.64%
Mar 31, 2024 -138.48%
Dec 31, 2023 -385.64%
Sep 30, 2023 -418.88%
Jun 30, 2023 -299.55%
Mar 31, 2023 -187.01%
Dec 31, 2022 -130.02%
Sep 30, 2022 -134.01%
Jun 30, 2022 -116.33%
Mar 31, 2022 -85.48%
Dec 31, 2021 -62.55%
API Access

Arcutis Biotherapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARQT&period=max&api_key=YOUR_API_KEY